New: Maxis AI Workforce now live across clinical operations.Learn more →

Maxis AI — THE FIRST AI WORKFORCE IN CLINICAL TRIALS
For SMB CRO

Agentic AI for SMB CRO

Compete with top-tier CROs through AI-led execution capacity, not larger teams.

SMB CROs compete for larger sponsor programs but are often constrained by perceived biometrics scale.

Maxis AI provides a supervised execution layer that demonstrates enterprise-grade biometrics capability during the bid process — unlocking access to larger programs.

Human-in-the-loop validation · Audit traceability

CAPACITY MULTIPLIER
Throughput
-55%
Manual ops
+40%
Win rate
Agentic AI Offerings

Our platform strengthens execution across key clinical workflows.

Clinical Data Management Automation

  • Automated data cleaning and validation
  • Reduced manual reconciliation effort

Statistical Programming Support

  • Automated dataset preparation
  • Improved biometrics efficiency

Operational Oversight and Monitoring

  • Earlier identification of delivery risks
  • Continuous workflow monitoring

Portfolio Oversight and Governance

  • Unified dashboards across trials
  • Improved sponsor delivery visibility
Operational Pressure

Where SMB CRO Delivery Often Slows

Execution constraints typically emerge due to:

Limited biometrics staffing capacity

Manual data reconciliation workflows

Difficulty scaling delivery across trials

Limited operational visibility

Sponsor concerns around scalability

Outcomes

What Improves with Agentic AI

With agentic AI for small CRO clinical operations teams, delivery becomes more scalable.

Reduced biometrics workload

Faster database readiness timelines

Improved delivery predictability

Improved scalability without staffing expansion

Stronger sponsor confidence

Recommended Approach

Deploy supervised statistical programming and RBQM workflows first. This enables SMB CROs to demonstrate enterprise-grade biometrics capability during the bid process — unlocking access to larger programs.

Case Study

SMB CRO Wins Enterprise Bids. 2–3× Growth. $200–400K Saved.

High programming costs and manual reconciliation limited scalability. See how a mid-sized CRO strengthened biometrics delivery without scaling only through hiring.

2–3×

Deal size growth

$200–400K

Per-trial savings

80–90%

Manual coordination reduced

100%

Milestone predictability

FAQ

All You Need to Know

They improve biometrics efficiency and reduce manual workload.

Yes. It improves efficiency and scalability.

Yes. Supervised execution expands delivery capacity and reduces reliance on FSP staffing, improving scalability without proportional headcount increases.

Biometrics workflows and database readiness timelines.

Yes. It supports scalable growth and competitiveness.

Looking for Agentic AI for clinical trials?

Explore the Agentic AI Platform.

See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.